Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Learn about a clinical trial designed to study the long-term effects of the GLP-1 receptor agonist semaglutide on eye health and how to enroll if you are eligible.
Returning to in-person appointments and standard diabetes care can sometimes mean switching your healthcare team to better suit your needs. Here are tips for...
Continuous glucose monitors (CGM) and other advancements in diabetes technology over the past decade have given people with diabetes a greater ability to manage their...
How a simple mindset trick transformed how I view blood sugars and use my diabetes data
A prescription discount card can be used to reduce out-of-pocket costs of diabetes medications
Mounjaro (tirzepatide), a first-of-its kind medication for treating type 2 diabetes, has been approved by the FDA after much anticipation. This new medication has been...
Sports are a great way for people to engage in healthy habits, and they can contribute to positive mental health outcomes as well. Shawn Laib describes the ways...
Diabetes affects the skin in ways people may not even realize. Read about this connection and learn how to maintain healthy skin.
Learn what some of the latest research says about the heart health benefits of diabetes drugs like SGLT-2 inhibitors, GLP-1 receptor agonists, and non-steroidal MRAs.
As a child of a person with diabetes, it can often feel as though the odds are stacked against you and those you love. Terrisha Buckley shares her experience learning...
A new resource to help people with diabetes choose devices that are right for them
At ATTD 2022, researchers discussed the latest research on pregnancy, menstrual cycles, and overall health outcomes in women with diabetes. Diabetes technology can be a...
India is a developing country where diabetes is highly prevalent. Leading endocrinologists shared how they use the messaging service WhatsApp and Professional CGMs to...
In April 2022, 32 of the world’s premier diabetes experts gathered in Barcelona, along with representatives from industry, advocacy, and regulatory bodies, to discuss...
Clinical trial results published by Lilly show that Tirzepatide could potentially be one of the most effective drugs ever developed for weight loss. Experts discuss...
​For the first time, Time in Range was used as the main outcome measured in a clinical trial for a diabetes medication. Read about the study results and implications.
What do these numbers mean, what’s the target, and how can they provide insight into better diabetes management? Example days included!
Find out more from experts about the latest advancements in continuous glucose monitoring, ketone monitors, and non-invasive technologies.
At ATTD 2022, several researchers presented on projects aimed at understanding and addressing the impact of hypoglycemia. While diabetes technology is helpful and...

Pages